Janux Therapeutics Announces Positive Initial Phase 1 Data For JANX011 In Healthy Volunteers, Supporting Planned Development In Patients With Autoimmune Disease

Baca artikel penuh

Dapatkan akses tanpa had kepada artikel dari Reuters dan semua sumber berita di TradingView.